Cargando…
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
SIMPLE SUMMARY: There are contradictory data about coronavirus disease (COVID-19) in patients with hematological malignancies. In this population-based study we evaluated severity and survival of unvaccinated patients with hematological malignancies (HM) and COVID-19 in the Madrid region, Spain, bet...
Ejemplares similares
-
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
por: García-Suárez, Julio, et al.
Publicado: (2020) -
Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study
por: Martinez-Lopez, Joaquin, et al.
Publicado: (2021) -
COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies
por: Martinez Lopez, Joaquin, et al.
Publicado: (2022) -
Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group
por: Bailén, Rebeca, et al.
Publicado: (2020) -
Pf Filamentous Phage Requires UvrD for Replication in Pseudomonas aeruginosa
por: Martínez, Eriel, et al.
Publicado: (2016)